Visirna Therapeutics is based in Pasadena, California. It has raised $60M in total funding. Latest round: Seed.
Visirna Therapeutics funding overview
Visirna Therapeutics is based in Pasadena, California. Visirna Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in April 2022. The round record for Visirna Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Borealis Ventures, Flagship Ventures, InterWest, Vivo Capital, Wildcat Ventures. 5 distinct backers are named across the disclosed rounds.
Visirna Therapeutics at a glance
Total raised
$60M
Latest round
Seed
Latest round date
April 2022
Headquarters
Pasadena, California
Notable investors
Borealis Ventures, Flagship Ventures, InterWest, Vivo Capital, Wildcat Ventures
Frequently asked about Visirna Therapeutics funding
How much has Visirna Therapeutics raised?
Visirna Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Visirna Therapeutics?
Borealis Ventures, Flagship Ventures, InterWest, Vivo Capital, Wildcat Ventures are named among the investors backing Visirna Therapeutics.
What was the latest Visirna Therapeutics funding round?
The most recent disclosed round is a Seed, announced in April 2022.
Where is Visirna Therapeutics based?
Visirna Therapeutics is based in Pasadena, California.
When did Visirna Therapeutics last raise?
The last disclosed Visirna Therapeutics round closed in April 2022 at Seed.
Visirna Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Pasadena below to benchmark round size and investor mix.
